The markets opened flat with the Dow adding 2 points to 21,410 ahead of Federal Reserve chair Janet Yellen's testimony before Congress. Nasdaq slipped 5 points to 6,171.
On the upside
Halcon Resources (NYSE: HK) will sell its Williston Basin assets for approximately $1.4 billion in cash to Bruin E&P Partners.
Arena Pharmaceuticals (Nasdaq: ARNA) reported positive results from a Phase 2 study of ralinepag to treat pulmonary arterial hypertension.
Amicus Therapeutics (Nasdaq: FOLD) to submit a new drug application for its Fabry disease treatment migalastat in the fourth quarter.
On the downside
Morgan Stanley downgraded Snap (NYSE: SNAP) from an Overweight rating to an Equal Weight rating and slashed its price target from $28 to $16.
Getty Realty (NYSE: GTY) priced its public offering of 4.1 million shares of common stock at the discounted price of $23.15 per share.
MKM Partners initiated coverage of Michael Kors (NYSE: KORS) with a Sell rating and a $26 price target.
In the broad market, declining issues barely edged out advancers by a slim margin on the NYSE while advancers narrowly outpaced decliners on Nasdaq. The broader S&P 500 eased a fraction to 2,426. Bitcoin added $2 to $2336.
